Summary
THE published results of therapeutic trials are the basis on which changes in medical practice are made today. The clinican is, therefore, required to read and critically assess large numbers of these and the magnitude of this task is daunting.
Our aim is to provide a quick but systematic method of identifying papers worthy of further evaluation. We then outline an approach to deciding whether the results of a therapeutic trial are likely to be both true and useful.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sackett, J. 1981. Department of Clinical Epidemiology & Biostatistics, McMaster University Health Sciences Centre, Hamilton, Ontario. How to read a clinical journal, Pts. I-V. Canadian Med. Ass. J. 124, 555–8, 703-10, 869-72, 985-90, 1156-62.
Wulff, H. R. 1976. Rational diagnosis and treatment. Blackwell Scientific Publications, Oxford.
Preston, T. A. 1977. Coronary artery surgery: a critical review. Raven Press, New York.
Feinstein, A. R. 1967: Clinical Judgement. The Williams and Wilkins Company, Baltimore.
Feinstein, A. R. 1977. Clinical Biostatistics. The CV Bosby Company, Saint Louis.
Hampton, J. R. 1981. Presentation and analysis of the results of clinical trials in cardiovascular disease. Br. Med. J. 282, 1371–3.
Committee of Principal Investigators. 1980. WHO co-operative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Lancet ii, 379–85.
Graham, I. M. 1982. Drugs and the prevention of death from myocardial infarction. Irish Med. J. 75, No. 8, 291–6.
Colton, T. 1974. Statistics in Medicine. Little, Brown and Company, Boston.
Furburg, C. D. 1978. Possible yields of various forms of intervention after myocardial infarction. In “Acute and long-term management of myocardial ischaemia. Ed. Hjalmarson A. and Wilhelmsen L. Publ. Astra. 309–11.
Anturane Reinfarction Trial Research Group. 1980. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. New Engl. J. Med. 298, 289–95.
Anturane Reinfarction Trial Research Group. 1978. Sulphinpyrazone in the prevention of sudden death after myocardial infarction. New Engl. J. Med. 302, 250–6.
A Multicentre International Study: Supplementary Report. 1977. Reduction in mortality after myocardial infarction with long-term beta-adreno-ceptor blockade. Br. Med. J. ii, 419–21.
Baber, N. S., Wainwright Evans, D., Howitt, G., Thomas, M., Wilson, C., Lewis, J. A. Davis, P. M., Hander, K., Tuson, R. 1980. Multicentre Post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Br. Heart J. 44, 96–100.
The Coronary Drug Project Research Group. 1980. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. New Engl. J. Med. 303, 1038–41.
Hjalmarson, A., Helitz, J., Malek, I., Ryden, L., Vedin, A., Waldenstrom, A., Wedel, H., Elmfeldt, D., Holmberg, S., Nyberg, G., Swedberg, K., Waagstein, F., Waldenstrom, J. Wilhelmsen, L., Whilhelmsson, C. 1981. Effect on mortality of metoprolol in acute mycordial infarction. Lancet ii, 823–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kay, E.W., Moore, D. & Graham, I.M. The evaluation of trials of medical therapy. I.J.M.S. 154, 71–79 (1985). https://doi.org/10.1007/BF02937146
Issue Date:
DOI: https://doi.org/10.1007/BF02937146